313 related articles for article (PubMed ID: 17961149)
1. Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases.
Keating DJ
J Neurochem; 2008 Jan; 104(2):298-305. PubMed ID: 17961149
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases.
Trushina E; McMurray CT
Neuroscience; 2007 Apr; 145(4):1233-48. PubMed ID: 17303344
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial abnormalities in muscle and other aging cells: classification, causes, and effects.
DiMauro S; Tanji K; Bonilla E; Pallotti F; Schon EA
Muscle Nerve; 2002 Nov; 26(5):597-607. PubMed ID: 12402281
[TBL] [Abstract][Full Text] [Related]
5. Protein aggregation, metals and oxidative stress in neurodegenerative diseases.
Tabner BJ; El-Agnaf OM; German MJ; Fullwood NJ; Allsop D
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1082-6. PubMed ID: 16246050
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria, oxidative stress and neurodegeneration.
Federico A; Cardaioli E; Da Pozzo P; Formichi P; Gallus GN; Radi E
J Neurol Sci; 2012 Nov; 322(1-2):254-62. PubMed ID: 22669122
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.
Lin MT; Beal MF
Nature; 2006 Oct; 443(7113):787-95. PubMed ID: 17051205
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and neurodegeneration: where are we now?
Halliwell B
J Neurochem; 2006 Jun; 97(6):1634-58. PubMed ID: 16805774
[TBL] [Abstract][Full Text] [Related]
9. Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress.
Wolf AM; Asoh S; Hiranuma H; Ohsawa I; Iio K; Satou A; Ishikura M; Ohta S
J Nutr Biochem; 2010 May; 21(5):381-9. PubMed ID: 19423317
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of mitochondrial disease.
Muravchick S
Adv Drug Deliv Rev; 2008; 60(13-14):1553-60. PubMed ID: 18647627
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of brain mitochondrial Lon protease by peroxynitrite precedes electron transport chain dysfunction.
Stanyer L; Jorgensen W; Hori O; Clark JB; Heales SJ
Neurochem Int; 2008 Sep; 53(3-4):95-101. PubMed ID: 18598728
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria as targets for chemotherapy.
Gogvadze V; Orrenius S; Zhivotovsky B
Apoptosis; 2009 Apr; 14(4):624-40. PubMed ID: 19205885
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunction in mouse trisomy 16 brain.
Bambrick LL; Fiskum G
Brain Res; 2008 Jan; 1188():9-16. PubMed ID: 18061151
[TBL] [Abstract][Full Text] [Related]
14. Age related mitochondrial degenerative disorders in humans.
Reeve AK; Krishnan KJ; Turnbull DM
Biotechnol J; 2008 Jun; 3(6):750-6. PubMed ID: 18512864
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.
Hauptmann S; Scherping I; Dröse S; Brandt U; Schulz KL; Jendrach M; Leuner K; Eckert A; Müller WE
Neurobiol Aging; 2009 Oct; 30(10):1574-86. PubMed ID: 18295378
[TBL] [Abstract][Full Text] [Related]
16. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases.
Mandemakers W; Morais VA; De Strooper B
J Cell Sci; 2007 May; 120(Pt 10):1707-16. PubMed ID: 17502481
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress in neurodegeneration: cause or consequence?
Andersen JK
Nat Med; 2004 Jul; 10 Suppl():S18-25. PubMed ID: 15298006
[TBL] [Abstract][Full Text] [Related]
18. [The role for oxidative stress in neurodegenerative diseases].
Shibata N; Kobayashi M
Brain Nerve; 2008 Feb; 60(2):157-70. PubMed ID: 18306664
[TBL] [Abstract][Full Text] [Related]
19. [From yeast to neurodegenerative diseases: ten years of exploration of mitochondrial dynamic disorders].
Lenaers G; Amati-Bonneau P; Delettre C; Chevrollier A; Verny C; Miléa D; Procaccio V; Bonneau D; Hamel C; Reynier P
Med Sci (Paris); 2010 Oct; 26(10):836-41. PubMed ID: 20929674
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions.
Chee F; Mudher A; Newman TA; Cuttle M; Lovestone S; Shepherd D
Biochem Soc Trans; 2006 Feb; 34(Pt 1):88-90. PubMed ID: 16417489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
